Role of thyroid stimulating hormone suppression in the management of thyroid cancer
β Scribed by Colin G. Thomas JR.
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 510 KB
- Volume
- 7
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
β¦ Synopsis
Well-differentiated thyroid cancers (papillary, follicular, and some Hurthle cell tumors) contain membrane receptors for TSH. Responsiveness of these tumors to TSH stimuli is documented by increased radioactive iodine uptake, secretion of thyroglobulin, increase in thyroid size, and potential progression to an anaplastic type. Although TSH suppression has a variable effect on the growth of existing tumors and the incidence of recurrent disease, there is a sound rationale for long-term TSH suppression in all patients with differentiated tumors of the thyroid. The ultrasensitive TSH test permits ready monitoring of the adequacy of thyroxine dosage. The cost is minimal (approximately $.lO/day) and the risks are negligible if one assumes the avoidance of hyperthyroxinemia.
π SIMILAR VOLUMES
Thyroids from rat fetuses of different ages (from day 14 to day 19 of gestation) were transplanted to organ culture for 2 days, with or without added thyroid-stimulating hormone (TSH) in the medium. Thyroid tissue from 14-day fetuses that initially consisted of irregularly arranged cell cords did no
## Abstract ## Background To determine the prognostic value of thyroid suppression therapy in patients with thyroid carcinoma, we studied the effect of thyroidβstimulating hormone (TSH) on the morphology, proliferation rate, and the T3, T4 production rate of primary thyroid carcinoma cells in cult
We studied the growth hormone (GH) response to GH-releasing hormone (GHRH) and the thyroid-stimulating hormone (TSH) response to thyrotropin-releasing hormone (TRH) in four groups of patients with dementia and examined whether GH and TSH secretion is altered in patients with Alzheimer's disease. The